StockData

BioLargo, Inc. (BLGO) stock

BLGOOTCChemicals & Allied ProductsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 0/30
$0.07+0.00 (+0.90%)

Close on Oct 19, 2026Market cap $23.27MP/E –Yield –

BioLargo total assets

Total assets on the balance sheet at the end of each period.

BioLargo's total assets was $6.67M at Jun 30, 2026. For fiscal 2025 it was $8.31M, down 20.9% from the year before. Over ten years it grew 15.8% a year on average. The highest annual figure on record is $10.51M in fiscal 2024.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$8.31M-20.9%
FY2024Dec 31, 2024$10.51M+28.1%
FY2023Dec 31, 2023$8.21M+68.9%
FY2022Dec 31, 2022$4.86M+60.7%
FY2021Dec 31, 2021$3.02M-38.8%
FY2020Dec 31, 2020$4.94M+36.5%
FY2019Dec 31, 2019$3.62M+13.7%
FY2018Dec 31, 2018$3.19M+112.9%
FY2017Dec 31, 2017$1.50M-29.2%
FY2016Dec 31, 2016$2.11M+10.6%
FY2015Dec 31, 2015$1.91M+632.8%
FY2014Dec 31, 2014$260.67K+55.9%
FY2013Dec 31, 2013$167.19K-37.8%
FY2012Dec 31, 2012$268.70K+9.1%
FY2011Dec 31, 2011$246.39K-46.4%
FY2010Dec 31, 2010$459.74K–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$6.67M-46.6%
Q1 FY2026Mar 31, 2026$8.57M-18.5%
Q4 FY2025Dec 31, 2025$8.31M-20.9%
Q3 FY2025Sep 30, 2025$9.13M-11.4%
Q2 FY2025Jun 30, 2025$12.50M+24.3%
Q1 FY2025Mar 31, 2025$10.51M+7.0%
Q4 FY2024Dec 31, 2024$10.51M+28.1%
Q3 FY2024Sep 30, 2024$10.31M+57.4%
Q2 FY2024Jun 30, 2024$10.05M+50.5%
Q1 FY2024Mar 31, 2024$9.82M+47.8%
Q4 FY2023Dec 31, 2023$8.21M+68.9%
Q3 FY2023Sep 30, 2023$6.55M+49.7%
Q2 FY2023Jun 30, 2023$6.68M+97.8%
Q1 FY2023Mar 31, 2023$6.65M+102.1%
Q4 FY2022Dec 31, 2022$4.86M+60.7%
Q3 FY2022Sep 30, 2022$4.37M-17.3%
Q2 FY2022Jun 30, 2022$3.38M-38.0%
Q1 FY2022Mar 31, 2022$3.29M-38.4%
Q4 FY2021Dec 31, 2021$3.02M-38.8%
Q3 FY2021Sep 30, 2021$5.28M+1.9%
Q2 FY2021Jun 30, 2021$5.45M+11.2%
Q1 FY2021Mar 31, 2021$5.34M+50.1%
Q4 FY2020Dec 31, 2020$4.94M+36.5%
Q3 FY2020Sep 30, 2020$5.19M+1.6%
Q2 FY2020Jun 30, 2020$4.90M+36.6%
Q1 FY2020Mar 31, 2020$3.56M+4.7%
Q4 FY2019Dec 31, 2019$3.62M+13.7%
Q3 FY2019Sep 30, 2019$5.10M+368.7%
Q2 FY2019Jun 30, 2019$3.58M+206.9%
Q1 FY2019Mar 31, 2019$3.40M+133.3%
Q4 FY2018Dec 31, 2018$3.19M+112.9%
Q3 FY2018Sep 30, 2018$1.09M-37.5%
Q2 FY2018Jun 30, 2018$1.17M+81.6%
Q1 FY2018Mar 31, 2018$1.46M-2.9%
Q4 FY2017Dec 31, 2017$1.50M-29.2%
Q3 FY2017Sep 30, 2017$1.74M-11.5%
Q2 FY2017Jun 30, 2017$642.95K–
Q1 FY2017Mar 31, 2017$1.50M–
Q4 FY2016Dec 31, 2016$2.11M–
Q3 FY2016Sep 30, 2016$1.97M–

More BioLargo figures

See a number that looks wrong?